Respecting the technical, delivering the practical

Our expert team will be at ISPOR Annual Montreal, Canada in May 2025. ISPOR is the leading global conference for Health Economics and Outcomes Research and the best place to discuss and disseminate the latest trends in healthcare.
Find out more
FIECON Joins Herspiegel to Expand Global Life Scie...
YARDLEY, PA and LONDON, UK – April 7, 2025 – Herspiegel, a world leader in pharmaceutical and biotech commercialization services, continues its strategic expansion by joining forces with FIECON.
Read more
Everything you always wanted to know about JCA
What is JCA?  Is my product eligible? The Joint Clinical Assessment (JCA) for oncology, haematology, and ATMPs will be eligible for assessment from January 12th, 2025 with two significant updates this month.
Read more
Welcome to price transparency with RFP Builder
By matching project requirements, the RFP Builder provides custom quotes, ensuring a perfect alignment with project needs without even having to speak to anyone at FIECON!
Explore pricing

Key services

We are committed to to supporting the commercialisation of products that make a difference in people’s lives. We work across a product’s lifecycle, to support pharma, med tech and biotech companies around the world.
Outcomes Research
Our team provide unequalled accuracy and quality whilst delivering all aspects of systematic reviews, meta-analyses and patient-level data analyses.
Economic Modelling
We develop a range of robust health economic models that meet the commercial needs of our clients from simple Markov models to complex discrete event simulations.
Health Technology Assessment
We have extensive experience delivering successful HTA submissions in the UK and across the globe.
Value Communication
At FIECON, we understand the value of clear and concise writing, underpinned by robust evidence. We effectively communicate the value of our clients' products in a clear, logical and impactful manner; from global value dossiers to external scientific publications.
Pricing & Reimbursement
We partner with our clients to develop strategies for global pricing and reimbursement, harnessing our extensive KOL and payer network.
Real World Evidence
Our team offers comprehensive real world evidence (RWE) services, including the development of tailored RWE strategies and conducting evidence gap analyses.

Keeping up to date

Starting a career to drive positive change
Grace Newman, a recent graduate who joined FIECON in September 2024, shares her journey and experiences as an Associate, offering insights for recent graduates interested in joining the team.
Read more
Stories over statistics: Richard and Caroline talk about Rare Disease
As Rare Disease Day approaches, Caroline, Associate Director at FIECON, and Richard, Head of Client Partnerships at FIECON, discuss the crucial role of HEOR in improving the lives of rare disease patients, and their families and care givers.
Read more
Why Saudi Arabia is the next key market for your Pharma Expansion
In this informative conversation, Lavni Varyani from Pharma BP discusses the evolving HTA process in Saudi Arabia. As a GCC market expert, Lavni explains how pharmaceutical companies can strategically engage with the market to navigate the upcoming HTA changes from both local and global perspectives.
Read more

Get in touch

Get a completely free, no-obligation opportunity to discuss your needs and see how we can boost your business.
  • Brainstorm solutions to key challenges with experienced team
  • Validate your strategy and value evidence
  • Learn more about FIECON’s products and key areas of expertise and discuss opportunities for collaboration

Your contact details

I would like to
By submitting this form, you confirm that you agree to our website terms of use

Thank you!

We received your details. Someone from our team will contact you soon.
Oops!
Something went wrong while submitting the form.